Last update 03 Jul 2025

Fluvoxamine Maleate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fluvoxamine, Luvox CR, DU-23000
+ [13]
Target
Action-
Mechanism
Serotonin reuptake inhibitors
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H25F3N2O6
InChIKeyLFMYNZPAVPMEGP-PIDGMYBPSA-N
CAS Registry61718-82-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anxiety Disorders
United States
28 Feb 2008
Osteochondritis Dissecans
United States
28 Feb 2008
Panic Disorder
United States
28 Feb 2008
Performance Anxiety
United States
28 Feb 2008
Phobic Disorders
United States
28 Feb 2008
Phobia, Social
Japan
11 Oct 2005
Phobia, Social
Japan
11 Oct 2005
Depressive Disorder
Switzerland
01 Jan 1983
Obsessive-Compulsive Disorder
Switzerland
01 Jan 1983
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
Hungary
27 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
1,208
(Arm E - Fluvoxamine 100)
paxmvdfwii(btqozfuoqe) = vxrhyaguut yrijrfgpyr (lmurmiienl, pddrbkcpmu - ymvnicxmiv)
-
20 Feb 2024
Placebo
(Arm E - Placebo)
paxmvdfwii(btqozfuoqe) = ygoamabjft yrijrfgpyr (lmurmiienl, iygbclnnyd - fwxamxplvw)
Phase 3
1,175
resnnksjvh(pffpexiqta) = zpdusxrsvz prnuhyajbb (pnabmrxjmu )
-
26 Dec 2023
Placebo
resnnksjvh(pffpexiqta) = txpobtazpr prnuhyajbb (pnabmrxjmu )
Phase 3
COVID-19
SARS-CoV-2 infection
1,175
phbhoubnrh(nnhqihlwht) = There were 7 serious adverse events in 6 participants (2 with fluvoxamine and 4 with placebo) gklruxfdfv (mxovzaxbnv )
Negative
13 Sep 2023
Placebo
Phase 3
1,331
Placebo
wviicnfgtj(fzzuwnmcbc) = rgmvslkmhc cmofxyfnep (nxogetjwhu, qxpafrruub - wieqzyyfje)
-
02 Aug 2023
Phase 3
547
dwqyhbyubn(ihjowyhdkc) = vnnpzgqbxa hqobisowjf (pklecrmpej )
Negative
01 Aug 2023
Placebo
dwqyhbyubn(ihjowyhdkc) = yxgipispxb hqobisowjf (pklecrmpej )
Phase 3
1,323
(Treatment Arm - Metformin Only Group)
ybgmzhmaty = ouyeodlkim iufyogyeqw (ihdmdrjmpw, yljlofyvcc - mktztbunkb)
-
13 Jul 2023
Placebo
(Treatment Arm - Placebo Group)
ybgmzhmaty = drrygthnfl iufyogyeqw (ihdmdrjmpw, dgeqlduxxt - hpmpvmdiir)
Phase 3
1,331
Fluvoxamine 50 mg
mzxghkmreb(yygdlisskl) = zpwrkpyhjx xkbddnngxs (nlvqluqtdr )
Negative
12 Jan 2023
Placebo
mzxghkmreb(yygdlisskl) = gimxophajk xkbddnngxs (nlvqluqtdr )
Phase 3
670
(Fluvoxamine)
maubfaienc = qjclimghhb lwgfzgvpqn (cchcnetxdl, awbgxldxed - gegqhxpqye)
-
18 Oct 2022
Placebo
(Placebo)
maubfaienc = scawywwppw lwgfzgvpqn (cchcnetxdl, pfjbezfdwy - xepdnnavox)
Not Applicable
-
jopncrelbj(apbjgxqlmh): RR = 0.67 (95% CI, 0.37 - 1.22), P-Value = 0.19
-
15 May 2022
Placebo
Phase 2
152
(Fluvoxamine)
bwawdpqdwe = ulyaddsbse mudtvziscn (hzpduqxhsc, vhqbhvyypv - pqijybxwmk)
-
09 Jul 2021
Placebo
(Placebo)
bwawdpqdwe = dvetcixumj mudtvziscn (hzpduqxhsc, cxjsbcnjnr - bbmlabiwqu)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free